Leadership Team

We treat your business like it is our own. Our commitment to our clients is reflected in the deep collaboration and involvement of our senior-most consultants across all of our projects.

Daniel J. Hawkins is a founder and Managing Director of Clarion Healthcare. Dan has over 20 years of experience in healthcare, having worked with companies ranging from global pharmaceutical companies to development stage biotech and device companies, as well as venture capital/private equity firms that invest in the industry.
See full bio

Carol M. Kearney, a Principal with Clarion Healthcare, brings over 15 years of industry and consulting experience. For the past six years with Clarion, Carol has worked with pharmaceutical clients developing solutions focused on improving field force and organizational effectiveness, defining commercialization strategies, preparing for and executing new product launches, and integrating managed care, medical affairs and marketing strategies.
See full bio

Bart J. Lombardi, a founder and Managing Director of Clarion, brings nearly 20 years’ experience in new product launches, commercialization strategy, managed care strategy, sales and marketing excellence, and organization transformation.
See full bio

Thomas Murtagh, a founder and Managing Director of Clarion Healthcare, brings significant expertise in new product management, product commercialization, and competitive strategy. He has worked extensively in CNS and oncology, and has worked across a wide variety of specialty markets.
See full bio

Petya Spletzer, a Principal with Clarion, has more than 10 years of consulting experience in the life sciences industry. Petya brings significant experience in new product marketing and commercialization in a wide range of areas, including CNS, cardiovascular, metabolic disorders, musculoskeletal and autoimmune disease.
See full bio

Gordon Walton, a founder and Managing Director of Clarion, brings nearly 20 years of experience to client engagements. He helps guide pharmaceutical and biotech companies to maximize their investments through portfolio management, competitive strategy, and organizational change.
See full bio